Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)
about
'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic StudiesDisGeNET: a discovery platform for the dynamical exploration of human diseases and their genesThematic review series: Adipocyte Biology. Lipodystrophies: windows on adipose biology and metabolism.PPARgamma in human and mouse physiologyClinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency.Human immunodeficiency virus (HIV)-1 viral protein R suppresses transcriptional activity of peroxisome proliferator-activated receptor {gamma} and inhibits adipocyte differentiation: implications for HIV-associated lipodystrophy.Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.Leptin therapy for partial lipodystrophy linked to a PPAR-gamma mutation.The role of Klotho in energy metabolism.New PPARG mutation leads to lipodystrophy and loss of protein function that is partially restored by a synthetic ligand.Decreased PPAR gamma expression compromises perigonadal-specific fat deposition and insulin sensitivity.Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.Novel peroxisome proliferator-activated receptor gamma mutation in a family with familial partial lipodystrophy type 3.Lipodystrophic laminopathies: Diagnostic clues.A Pharmacogenetic Approach to the Treatment of Patients with PPARG Mutations.Monogenic Causes of Diabetes
P2860
Q28221639-E38DF4D1-43F3-4E32-94ED-F97D8C89E726Q28649649-98A5E0D6-B453-48BB-8D90-AC82408832EDQ34610713-A0DCBA1A-0356-4691-9F6B-12BEB872CC53Q36063081-351A2772-FAA6-4F16-B60A-8117D190671EQ36145262-B697AFB9-40E8-4436-AE20-1E77343F23BDQ36447407-C0E9E6B5-771D-4CC6-9C60-D6307C05C99AQ36734086-A8B20834-E125-4A92-90FB-6CFD4C686CDAQ36962898-1B9D5175-FC39-431A-8B52-36DB24221DFBQ36992839-EC2A9878-E2CC-48E1-8F5E-B870BF0F49B6Q37004608-66D36757-8C0E-448F-BDAE-5E88B36B5861Q37418165-2C0F9EF2-F800-4A39-BAF6-081BDE2B53BFQ45981116-D0A358F2-D1F2-4122-A844-FD5D7C13C130Q51011749-C1DBF66A-1BD6-4F7F-BBBB-F075975F2CDBQ51761347-780A7695-5E50-44C7-B6DF-B4C926760884Q52721267-4906F520-18F3-48A1-80AF-A55C143F0794Q57915399-E565F591-0BB6-4D95-9ACC-403300BC836D
P2860
Peroxisomal proliferator activated receptor-gamma deficiency in a Canadian kindred with familial partial lipodystrophy type 3 (FPLD3)
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@ast
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@en
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@nl
type
label
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@ast
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@en
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@nl
prefLabel
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@ast
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@en
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@nl
P2093
P2860
P356
P1433
P1476
Peroxisomal proliferator activ ...... l lipodystrophy type 3 (FPLD3)
@en
P2093
Gordon A Francis
Henian Cao
Robin Casey
P2860
P2888
P356
10.1186/1471-2350-7-3
P407
P577
2006-01-14T00:00:00Z
P5875
P6179
1040524944